Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection

Maria Chiara Parati1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy

Rebecca Pedersini2 Breast Unit-Medical Oncology, ASST Spedali Civili, Brescia, Italy

Gianluca Perego3 Pharmacy Unit, IRCCS San Raffaele Hospital, Milan, Italy

Roberto Reduzzi4 Breast Unit, ASST Bergamo Ovest, Treviglio, BG, Italy

Tommaso Savio4 Breast Unit, ASST Bergamo Ovest, Treviglio, BG, Italy

Mary Cabiddu1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy

Karen Borgonovo1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy

Mara Ghilardi1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy

Andrea Luciani1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy

Fausto Petrelli1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, ItalyCorrespondence[email protected]

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.